(Q27852366)
Statements
1 reference
A clinically relevant androgen receptor mutation confers resistance to second-generation antiandrogens enzalutamide and ARN-509. (English)
1 reference
September 2013
0 references
3
0 references
9
0 references
1020-9
0 references